Juvenile Idiopathic Arthritis

Largest, most representative JIA data registry available for licensing, analytics, and collaboration

Research-Grade RWD in JIA

Disease with no cure

With no cure for JIA, early diagnosis and effective treatment are the best ways to help reduce damaging effects and improve patients’ quality of life.

5,200+*

JIA patients followed prospectively with deep clinical, lab, and other linked data

*Counts complete through Q2 2024

69,000+*

JIA patients in the OM1 Real-World Data Cloud that can be used for modeling, analysis, and other research purposes

Specialized Data

Why OM1 JIA?

Sample Use Cases

» Feasibility	» Comparative Effectiveness
» Passive Safety	» Natural History

Webinar: Real-World Data for R&D for Autoimmune & Chronic Diseases

Posters

Patient Characteristics and Management Of Juvenile Idiopathic Arthritis (JIA) In a Large, Representative Real-World Cohort

Award-Winning Research Team

Our team of award-winning researchers have authored hundreds of publications, including scientific posters, articles in peer-reviewed journals, white papers, and books.

View All Rheumatology Publications

Request a Meeting

Name*
First Last
Company Name*
Job Title*
Email*
Message*
Phone
This field is for validation purposes and should be left unchanged.